Farhan Jalees Ahmad
Overview
Explore the profile of Farhan Jalees Ahmad including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1579
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dongsar T, Bajaj K, Dongsar T, Ali A, Hasan N, Ahmad F
Curr Cancer Drug Targets
. 2025 Feb;
PMID: 39945253
Skin cancer is one of the most lethal cancers today, posing significant challenges to public health and potentially impacting global health and economic stability. Due to its high rate of...
2.
Ali I, Adil M, Imran M, Qureshi S, Qureshi S, Hasan N, et al.
Drug Deliv Transl Res
. 2025 Jan;
PMID: 39878857
The global prevalence of Parkinson's Disease (PD) is on the rise, driven by an ageing population and ongoing environmental conditions. To gain a better understanding of PD pathogenesis, it is...
3.
Recent Advances in Nanocarrier-mediated Combination Drug Therapy for Tackling Solid-resistant Tumors
Rafiya K, Awasthi S, Qureshi S, Hasan N, Ahmad F
Curr Drug Deliv
. 2025 Jan;
PMID: 39819405
Cancer is a group of dynamic diseases characterized by uncontrollable growth and spread of cells. The heterogenic nature of cancer hinders the abolishment of cancer resulting in a narrow therapeutic...
4.
Alruwaili N, Almalki W, Salman Almujri S, Alhamyani A, Alzahrani A, Aodah A, et al.
Nanomedicine (Lond)
. 2024 Oct;
19(30):2555-2576.
PMID: 39404092
The present study aims to develop, optimize and assess hispolon (HPN) lipid nanocapsules (LNCs), solid lipid nanoparticles (SLNs) and suspension for treating hepatocellular carcinoma (HCC). It included UPLC-MS/MS, solubility, optimization,...
5.
Solanki R, Malik M, Alankar B, Ahmad F, Dohare R, Chauhan R, et al.
Pathol Res Pract
. 2024 Jul;
260:155431.
PMID: 39029376
A better understanding of incidences at the cellular level in uterine cancer is necessary for its effective treatment and favourable prognosis. Till date, it lacks appropriate molecular target-based treatment because...
6.
Qureshi S, Rafiya K, Awasthi S, Jain A, Nadaf A, Hasan N, et al.
Colloids Surf B Biointerfaces
. 2024 Apr;
238:113893.
PMID: 38631282
Targeted drug delivery has emerged as a pivotal approach within precision medicine, aiming to optimize therapeutic efficacy while minimizing systemic side effects. Advanced biomimetic membrane-coated formulations have garnered significant interest...
7.
Ashique S, Faruk A, Ahmad F, Khan T, Mishra N
Probiotics Antimicrob Proteins
. 2023 Oct;
16(3):979-992.
PMID: 37880560
Cervical cancer (CC) is the fourth most common malignancy in female patients. "Human papillomavirus" (HPV) contamination is a leading cause of all forms of cervical cancer, accounting for an expected...
8.
Hasan N, Nadaf A, Imran M, Jiba U, Sheikh A, Almalki W, et al.
Mol Cancer
. 2023 Oct;
22(1):168.
PMID: 37803407
Skin cancer is a global threat to the healthcare system and is estimated to incline tremendously in the next 20 years, if not diagnosed at an early stage. Even though...
9.
Hasan N, Imran M, Jain D, Jha S, Nadaf A, Chaudhary A, et al.
Environ Res
. 2023 Sep;
238(Pt 1):117007.
PMID: 37689337
Targeted drug delivery has emerged as a pivotal approach within precision medicine, aiming to optimize therapeutic efficacy while minimizing systemic side effects. Leukocyte membrane coated nanoparticles (NPs) have attracted a...
10.
Chandra J, Hasan N, Nasir N, Wahab S, Thanikachalam P, Sahebkar A, et al.
Environ Res
. 2023 Jul;
235:116649.
PMID: 37451568
In current scenario skin cancer is a serious condition that has a significant impact on world health. Skin cancer is divided into two categories: melanoma skin cancer (MSC) and non-melanoma...